{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T08:09:56Z","timestamp":1761725396462,"version":"build-2065373602"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013209","name":"Hellenic Foundation for Research and Innovation","doi-asserted-by":"publisher","award":["472-EpiNotch","3218-EpiCS"],"award-info":[{"award-number":["472-EpiNotch","3218-EpiCS"]}],"id":[{"id":"10.13039\/501100013209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-025-01101-6","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:33:05Z","timestamp":1761661985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KMT2C inactivation leads to PTEN downregulation and tolerance to DNA damage during cell cycle progression"],"prefix":"10.1038","volume":"9","author":[{"given":"Theodoros","family":"Rampias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Goutas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Karagiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoi","family":"Kanaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antigoni","family":"Makri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Hoxhallari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fotini E.","family":"Koukouzeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varvara","family":"Paraskevopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Tsouraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Paschalidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaritis","family":"Avgeris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Scorilas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Klinakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"1101_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrg.2016.13","volume":"17","author":"AP Feinberg","year":"2016","unstructured":"Feinberg, A. P., Koldobskiy, M. A. & Gondor, A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat. Rev. Genet. 17, 284\u2013299 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"1101_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev-biochem-051710-134100","volume":"81","author":"A Shilatifard","year":"2012","unstructured":"Shilatifard, A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu. Rev. Biochem. 81, 65\u201395 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"1101_CR3","doi-asserted-by":"publisher","first-page":"12902","DOI":"10.1073\/pnas.231473398","volume":"98","author":"T Miller","year":"2001","unstructured":"Miller, T. et al. COMPASS: A complex of proteins associated with a trithorax-related SET domain protein. Proc. Natl Acad. Sci. 98, 12902\u201312907 (2001).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1101_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-9-r106","volume":"14","author":"A Gonzalez-Perez","year":"2013","unstructured":"Gonzalez-Perez, A., Jene-Sanz, A. & Lopez-Bigas, N. The mutational landscape of chromatin regulatory factors across 4,623 tumor samples. Genome Biol. 14, r106 (2013).","journal-title":"Genome Biol."},{"key":"1101_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333\u2013339 (2013).","journal-title":"Nature"},{"key":"1101_CR6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nrc3929","volume":"15","author":"RC Rao","year":"2015","unstructured":"Rao, R. C. & Dou, Y. Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Nat. Rev. Cancer 15, 334\u2013346 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"1101_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"Cancer Genome Atlas Research, N.","year":"2014","unstructured":"Cancer Genome Atlas Research, N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315\u2013322 (2014).","journal-title":"Nature"},{"key":"1101_CR8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson, A. G. et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171, 540\u2013556 e525 (2017).","journal-title":"Cell"},{"key":"1101_CR9","doi-asserted-by":"publisher","first-page":"8513","DOI":"10.1073\/pnas.0902873106","volume":"106","author":"J Lee","year":"2009","unstructured":"Lee, J. et al. A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4. Proc. Natl. Acad. Sci. USA 106, 8513\u20138518 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1101_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41588-024-02015-y","volume":"57","author":"N Wang","year":"2025","unstructured":"Wang, N. et al. Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promoters. Nat. Genet 57, 165\u2013179 (2025).","journal-title":"Nat. Genet"},{"key":"1101_CR11","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1101_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"O Sanli","year":"2017","unstructured":"Sanli, O. et al. Bladder cancer. Nat. Rev. Dis. Prim. 3, 17022 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1101_CR13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ccell.2017.08.005","volume":"32","author":"CD Hurst","year":"2017","unstructured":"Hurst, C. D. et al. Genomic subtypes of non-invasive bladder cancer with distinct metabolic profile and female gender bias in KDM6A mutation frequency. Cancer Cell 32, 701\u2013715 e707 (2017).","journal-title":"Cancer Cell"},{"key":"1101_CR14","doi-asserted-by":"publisher","unstructured":"Rampias, T. et al. The lysine-specific methyltransferase KMT2C\/MLL3 regulates DNA repair components in cancer. EMBO Rep. 20, https:\/\/doi.org\/10.15252\/embr.201846821 (2019).","DOI":"10.15252\/embr.201846821"},{"key":"1101_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22465-w","volume":"12","author":"SV Lindskrog","year":"2021","unstructured":"Lindskrog, S. V. et al. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat. Commun. 12, 2301 (2021).","journal-title":"Nat. Commun."},{"key":"1101_CR16","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1083\/jcb.201902085","volume":"218","author":"J Michelena","year":"2019","unstructured":"Michelena, J., Gatti, M., Teloni, F., Imhof, R. & Altmeyer, M. Basal CHK1 activity safeguards its stability to maintain intrinsic S-phase checkpoint functions. J. Cell Biol. 218, 2865\u20132875 (2019).","journal-title":"J. Cell Biol."},{"key":"1101_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molcel.2018.05.026","volume":"71","author":"B Lemmens","year":"2018","unstructured":"Lemmens, B. et al. DNA replication determines timing of mitosis by restricting CDK1 and PLK1 activation. Mol. Cell 71, 117\u2013128 e113 (2018).","journal-title":"Mol. Cell"},{"key":"1101_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108096","volume":"32","author":"MD Rainey","year":"2020","unstructured":"Rainey, M. D. et al. ATR restrains DNA synthesis and mitotic catastrophe in response to CDC7 inhibition. Cell Rep. 32, 108096 (2020).","journal-title":"Cell Rep."},{"key":"1101_CR19","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/nm.3678","volume":"20","author":"T Rampias","year":"2014","unstructured":"Rampias, T. et al. A new tumor suppressor role for the Notch pathway in bladder cancer. Nat. Med. 20, 1199\u20131205 (2014).","journal-title":"Nat. Med."},{"key":"1101_CR20","doi-asserted-by":"crossref","unstructured":"Riester, M. et al. Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. Clin. Cancer Res. 18, 1323\u20131333 (2012).","DOI":"10.1158\/1078-0432.CCR-11-2271"},{"key":"1101_CR21","doi-asserted-by":"publisher","unstructured":"Zhu, C. et al. MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer. Elife 12, https:\/\/doi.org\/10.7554\/eLife.80854 (2023).","DOI":"10.7554\/eLife.80854"},{"key":"1101_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature07185","volume":"455","author":"L Macurek","year":"2008","unstructured":"Macurek, L. et al. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 455, 119\u2013123 (2008).","journal-title":"Nature"},{"key":"1101_CR23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.molcel.2004.07.015","volume":"15","author":"MA van Vugt","year":"2004","unstructured":"van Vugt, M. A., Bras, A. & Medema, R. H. Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol. Cell 15, 799\u2013811 (2004).","journal-title":"Mol. Cell"},{"key":"1101_CR24","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.1157425","volume":"320","author":"A Seki","year":"2008","unstructured":"Seki, A., Coppinger, J. A., Jang, C. Y., Yates, J. R. & Fang, G. Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. Science 320, 1655\u20131658 (2008).","journal-title":"Science"},{"key":"1101_CR25","doi-asserted-by":"publisher","unstructured":"Joukov, V. & De Nicolo, A. Aurora-PLK1 cascades as key signaling modules in the regulation of mitosis. Sci. Signal. 11, https:\/\/doi.org\/10.1126\/scisignal.aar4195 (2018).","DOI":"10.1126\/scisignal.aar4195"},{"key":"1101_CR26","doi-asserted-by":"publisher","first-page":"10848","DOI":"10.1073\/pnas.1831408100","volume":"100","author":"TC Hallstrom","year":"2003","unstructured":"Hallstrom, T. C. & Nevins, J. R. Specificity in the activation and control of transcription factor E2F-dependent apoptosis. Proc. Natl. Acad. Sci. USA 100, 10848\u201310853 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1101_CR27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1101\/gad.1345006","volume":"20","author":"TC Hallstrom","year":"2006","unstructured":"Hallstrom, T. C. & Nevins, J. R. Jab1 is a specificity factor for E2F1-induced apoptosis. Genes Dev. 20, 613\u2013623 (2006).","journal-title":"Genes Dev."},{"key":"1101_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2007.11.031","volume":"13","author":"TC Hallstrom","year":"2008","unstructured":"Hallstrom, T. C., Mori, S. & Nevins, J. R. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 13, 11\u201322 (2008).","journal-title":"Cancer Cell"},{"key":"1101_CR29","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc2401","volume":"8","author":"ES Knudsen","year":"2008","unstructured":"Knudsen, E. S. & Knudsen, K. E. Tailoring to RB: tumour suppressor status and therapeutic response. Nat. Rev. Cancer 8, 714\u2013724 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"1101_CR30","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1016\/j.yexcr.2013.09.012","volume":"319","author":"Z Zhou","year":"2013","unstructured":"Zhou, Z. et al. p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex. Exp. Cell Res. 319, 3104\u20133115 (2013).","journal-title":"Exp. Cell Res."},{"key":"1101_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1673-8527(08)60030-2","volume":"35","author":"M Tategu","year":"2008","unstructured":"Tategu, M. et al. Transcriptional regulation of human polo-like kinases and early mitotic inhibitor. J. Genet. Genom. 35, 215\u2013224 (2008).","journal-title":"J. Genet. Genom."},{"key":"1101_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"EP Consortium","year":"2012","unstructured":"Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012).","journal-title":"Nature"},{"key":"1101_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cell.2007.12.033","volume":"132","author":"A Sakaue-Sawano","year":"2008","unstructured":"Sakaue-Sawano, A. et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132, 487\u2013498 (2008).","journal-title":"Cell"},{"key":"1101_CR34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature18325","volume":"535","author":"A Ray Chaudhuri","year":"2016","unstructured":"Ray Chaudhuri, A. et al. Replication fork stability confers chemoresistance in BRCA-deficient cells. Nature 535, 382\u2013387 (2016).","journal-title":"Nature"},{"key":"1101_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.radonc.2011.09.021","volume":"101","author":"GE Pantelias","year":"2011","unstructured":"Pantelias, G. E. & Terzoudi, G. I. A standardized G2-assay for the prediction of individual radiosensitivity. Radiother. Oncol. 101, 28\u201334 (2011).","journal-title":"Radiother. Oncol."},{"key":"1101_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108652","volume":"34","author":"N Shindo","year":"2021","unstructured":"Shindo, N., Otsuki, M., Uchida, K. S. K. & Hirota, T. Prolonged mitosis causes separase deregulation and chromosome nondisjunction. Cell Rep. 34, 108652 (2021).","journal-title":"Cell Rep."},{"key":"1101_CR37","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature11935","volume":"494","author":"RA Burrell","year":"2013","unstructured":"Burrell, R. A. et al. Replication stress links structural and numerical cancer chromosomal instability. Nature 494, 492\u2013496 (2013).","journal-title":"Nature"},{"key":"1101_CR38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fonc.2014.00140","volume":"4","author":"A Burgess","year":"2014","unstructured":"Burgess, A., Rasouli, M. & Rogers, S. Stressing mitosis to death. Front. Oncol. 4, 140 (2014).","journal-title":"Front. Oncol."},{"key":"1101_CR39","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/jcmm.13018","volume":"21","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z., Zhang, G. & Kong, C. Targeted inhibition of Polo-like kinase 1 by a novel small-molecule inhibitor induces mitotic catastrophe and apoptosis in human bladder cancer cells. J. Cell. Mol. Med. 21, 758\u2013767 (2017).","journal-title":"J. Cell. Mol. Med."},{"key":"1101_CR40","doi-asserted-by":"publisher","first-page":"e111060","DOI":"10.1371\/journal.pone.0111060","volume":"9","author":"DL Driscoll","year":"2014","unstructured":"Driscoll, D. L. et al. Plk1 inhibition causes post-mitotic DNA damage and senescence in a range of human tumor cell lines. PLoS ONE 9, e111060 (2014).","journal-title":"PLoS ONE"},{"key":"1101_CR41","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/gerona\/glt017","volume":"68","author":"HJ Kim","year":"2013","unstructured":"Kim, H. J., Cho, J. H. & Kim, J. R. Downregulation of Polo-like kinase 1 induces cellular senescence in human primary cells through a p53-dependent pathway. J. Gerontol. A Biol. Sci. Med. Sci. 68, 1145\u20131156 (2013).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"1101_CR42","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/acel.12545","volume":"16","author":"K Evangelou","year":"2017","unstructured":"Evangelou, K. et al. Robust, universal biomarker assay to detect senescent cells in biological specimens. Aging Cell 16, 192\u2013197 (2017).","journal-title":"Aging Cell"},{"key":"1101_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/0008-5472.CAN-18-1304","volume":"79","author":"L Ma","year":"2019","unstructured":"Ma, L. et al. Aberrant activation of beta-catenin signaling drives glioma tumorigenesis via USP1-mediated stabilization of EZH2. Cancer Res. 79, 72\u201385 (2019).","journal-title":"Cancer Res."},{"key":"1101_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03031-6","volume":"11","author":"B Li","year":"2020","unstructured":"Li, B., Li, A., You, Z., Xu, J. & Zhu, S. Epigenetic silencing of CDKN1A and CDKN2B by SNHG1 promotes the cell cycle, migration and epithelial-mesenchymal transition progression of hepatocellular carcinoma. Cell Death Dis. 11, 823 (2020).","journal-title":"Cell Death Dis."},{"key":"1101_CR45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","volume":"19","author":"YR Lee","year":"2018","unstructured":"Lee, Y. R., Chen, M. & Pandolfi, P. P. The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat. Rev. Mol. Cell Biol. 19, 547\u2013562 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1101_CR46","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ijc.20447","volume":"112","author":"S Khan","year":"2004","unstructured":"Khan, S. et al. PTEN promoter is methylated in a proportion of invasive breast cancers. Int. J. Cancer 112, 407\u2013410 (2004).","journal-title":"Int. J. Cancer"},{"key":"1101_CR47","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.1158\/0008-5472.CAN-06-0384","volume":"66","author":"A Mirmohammadsadegh","year":"2006","unstructured":"Mirmohammadsadegh, A. et al. Epigenetic silencing of the PTEN gene in melanoma. Cancer Res. 66, 6546\u20136552 (2006).","journal-title":"Cancer Res."},{"key":"1101_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO;2-S","volume":"91","author":"HB Salvesen","year":"2001","unstructured":"Salvesen, H. B. et al. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J. Cancer 91, 22\u201326 (2001).","journal-title":"Int J. Cancer"},{"key":"1101_CR49","first-page":"1178","volume":"8","author":"JC Soria","year":"2002","unstructured":"Soria, J. C. et al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin. Cancer Res. 8, 1178\u20131184 (2002).","journal-title":"Clin. Cancer Res."},{"key":"1101_CR50","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1158\/2159-8290.CD-18-0083","volume":"9","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. PTEN methylation by NSD2 controls cellular sensitivity to DNA damage. Cancer Discov. 9, 1306\u20131323 (2019).","journal-title":"Cancer Discov."},{"key":"1101_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-021-00329-8","volume":"10","author":"M Fernando","year":"2021","unstructured":"Fernando, M. et al. Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours. Oncogenesis 10, 41 (2021).","journal-title":"Oncogenesis"},{"key":"1101_CR52","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1158\/0008-5472.CAN-21-0688","volume":"81","author":"A Chang","year":"2021","unstructured":"Chang, A. et al. Recruitment of KMT2C\/MLL3 to DNA damage sites mediates DNA damage responses and regulates PARP inhibitor sensitivity in cancer. Cancer Res. 81, 3358\u20133373 (2021).","journal-title":"Cancer Res."},{"key":"1101_CR53","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ceb.2007.02.009","volume":"19","author":"J Bartek","year":"2007","unstructured":"Bartek, J. & Lukas, J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr. Opin. Cell Biol. 19, 238\u2013245 (2007).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1101_CR54","doi-asserted-by":"publisher","unstructured":"Wakida, T. et al. The CDK-PLK1 axis targets the DNA damage checkpoint sensor protein RAD9 to promote cell proliferation and tolerance to genotoxic stress. Elife 6, https:\/\/doi.org\/10.7554\/eLife.29953 (2017).","DOI":"10.7554\/eLife.29953"},{"key":"1101_CR55","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejphar.2008.06.062","volume":"591","author":"C Didier","year":"2008","unstructured":"Didier, C., Cavelier, C., Quaranta, M., Demur, C. & Ducommun, B. Evaluation of Polo-like Kinase 1 inhibition on the G2\/M checkpoint in Acute Myelocytic Leukaemia. Eur. J. Pharm. 591, 102\u2013105 (2008).","journal-title":"Eur. J. Pharm."},{"key":"1101_CR56","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/cncr.28519","volume":"120","author":"WM Stadler","year":"2014","unstructured":"Stadler, W. M. et al. An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer. Cancer 120, 976\u2013982 (2014).","journal-title":"Cancer"},{"key":"1101_CR57","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 173, 371\u2013385.e318 (2018).","journal-title":"Cell"},{"key":"1101_CR58","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1242\/jcs.195164","volume":"130","author":"SB Koh","year":"2017","unstructured":"Koh, S. B. et al. A quantitative FastFUCCI assay defines cell cycle dynamics at a single-cell level. J. Cell Sci. 130, 512\u2013520 (2017).","journal-title":"J. Cell Sci."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01101-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01101-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01101-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:04:12Z","timestamp":1761699852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01101-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1101"],"URL":"https:\/\/doi.org\/10.1038\/s41698-025-01101-6","relation":{},"ISSN":["2397-768X"],"issn-type":[{"type":"electronic","value":"2397-768X"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"336"}}